Holen Sie sich die Stockscreener-App
166.97
18.55%
-38.03
Vorhandelsmarkt:
163.70
-3.27
-1.96%
Schlusskurs vom Vortag:
$205.00
Offen:
$209.55
24-Stunden-Volumen:
8.53M
Relative Volume:
4.80
Marktkapitalisierung:
$11.07B
Einnahmen:
$409.48M
Nettoeinkommen (Verlust:
$-81.28M
KGV:
-125.67
EPS:
-1.3286
Netto-Cashflow:
$-95.14M
1W Leistung:
-10.29%
1M Leistung:
+33.88%
6M Leistung:
+226.24%
1J Leistung:
+424.24%
1-Tages-Spanne:
$164.49
$219.71
1-Wochen-Bereich:
$164.49
$219.71
52-Wochen-Spanne:
$23.30
$219.71
Twist Bioscience Corp Stock (TWST) Company Profile
Firmenname
Twist Bioscience Corp
Sektor
Branche
Telefon
800-719-0671
Adresse
681 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA
Compare TWST vs TMO, DHR, NTRA, A, WAT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TWST
Twist Bioscience Corp
|
166.97 | 12.12B | 409.48M | -81.28M | -95.14M | -1.3286 |
TMO
Thermo Fisher Scientific Inc
|
656.58 | 241.26B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
215.61 | 150.48B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
400.65 | 59.47B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
169.33 | 48.71B | 7.23B | 1.41B | 1.09B | 4.979 |
WAT
Waters Corp
|
436.43 | 42.59B | 3.77B | 449.25M | 240.68M | 7.8556 |
Twist Bioscience Corp Stock (TWST) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-04 | Eingeleitet | Stephens | Overweight |
| 2024-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2024-06-04 | Eingeleitet | Guggenheim | Buy |
| 2024-01-17 | Hochstufung | Goldman | Neutral → Buy |
| 2023-09-27 | Eingeleitet | Berenberg | Buy |
| 2023-01-05 | Eingeleitet | Scotiabank | Sector Outperform |
| 2023-01-03 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2022-03-02 | Fortgesetzt | Cowen | Outperform |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-06-29 | Eingeleitet | William Blair | Outperform |
| 2021-06-04 | Eingeleitet | Goldman | Neutral |
| 2021-04-12 | Eingeleitet | Piper Sandler | Overweight |
| 2021-02-05 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2021-01-04 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2020-10-20 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2019-05-31 | Eingeleitet | Evercore ISI | Outperform |
| 2018-11-26 | Eingeleitet | JP Morgan | Neutral |
Alle ansehen
Twist Bioscience Corp Aktie (TWST) Neueste Nachrichten
After a $56.3M sale, a Twist Bioscience (NASDAQ: TWST) officer proposes selling more shares. - Stock Titan
Revenue per share of Twist Bioscience Corp. – HAN:0ME - TradingView
TWST Maintained by Leerink Partners -- Price Target Raised to $1 - GuruFocus
What Twist Bioscience (TWST)'s Lilly TuneLab Deal Means For Shareholders - Simply Wall Street
Form 144 Twist Bioscience Corp For: 28 September By Investing.com - Investing.com Nigeria
Twist Bioscience Corp (Derivatives) Price History and Historical Data - CoinMarketCap
Twist Bioscience SVP Paula Green sells $48,654 in common stock - Investing.com
Twist Bioscience CEO Emily Leproust sells $279,183 in stock - Investing.com
Form 4 Twist Bioscience Corp For: 27 September By Investing.com - Investing.com Australia
Twist Bioscience CEO Emily Leproust sells $279,183 in stock By Investing.com - Investing.com Australia
What Needs To Be True To Buy Twist Bioscience Stock Now? - Yahoo Finance
Under a June trading plan, Twist Bioscience (TWST) CEO Emily M. Leproust sold 5,203 shares in 10 transactions. - Stock Titan
Twist Bioscience Stock Hits New High, Then Retreats: What's Happening? - Benzinga
Biotech Stocks At 52-Week HighsCDNA +13%, GRAL +15%, TWST +16%, ADPT, RVTY - RTTNews
Twist Bioscience Stock Jumped 16% Thursday. Leerink Says Anthropic Made It Happen. - Yahoo Finance
U.S. Markets Finished Mixed Thursday As Twist Bioscience Led, Gen Digital Lagged - Barron's
Form 144 Twist Bioscience Corp For: 24 September By Investing.com - Investing.com Nigeria
A proposed share sale valued at $922,906 names Emily M. Leproust as the Twist Bioscience (TWST) account holder. - Stock Titan
Twist Bioscience Shares Hit New 52-Week High - AskTraders
Twist Bioscience TWST Surges On Lilly AI Deal, Target Hike - StocksToTrade
Twist Bioscience Corp Stock (TWST) Moved Up by 11.04% on Sep 24: A Full Analysis - TradingKey
Twist Bioscience Stock Jumps On Lilly AI Drug Discovery Deal - StocksToTrade
Twist Bioscience stock hits 52-week high at 170.69 USD - Investing.com
Twist Bioscience stock hits 52-week high at 170.69 USD By Investing.com - Investing.com Nigeria
TWST Forecast — Price Target — Prediction for 2027 - TradingView
ETFs Investing in Twist Bioscience Corp. Stocks - TradingView
EBITDA of Twist Bioscience Corp. – BMV:TWST - TradingView
Twist Bioscience Corp. Revenue Breakdown – BMV:TWST - TradingView
At $165.4910 a share, Twist Bioscience (TWST) CEO Emily M. Leproust sold stock to cover taxes. - Stock Titan
A required tax-withholding sale: Twist Bioscience (TWST) HR executive Paula Green sells 294 shares. - Stock Titan
Twist Bioscience Corporation (TWST) stock price, news, quote and history - Yahoo Finance UK
Twist Bioscience Corporation (TWST) Stock Price, News, Quote & History - Yahoo! Finance Canada
Twist Bioscience (TWST) Institutional Ownership 2026 $TWST - MarketBeat
Twist Bioscience Corporation (TWST) Latest Stock News & HeadlinesYahoo Finance - Yahoo! Finance Canada
Form 144 Twist Bioscience Corp For: 22 September By Investing.com - Investing.com Canada
Twist Bioscience (TWST) Expands AI Drug Discovery Exposure With Lilly TuneLab Partnership - Insider Monkey
Twist Bioscience CEO Emily Leproust sells $56.3m in company stock - Investing.com
After $56M sale, Twist Bioscience (NASDAQ: TWST) insider plans more - Stock Titan
Twist Bioscience (TWST) officer to sell shares to cover tax on equity award - Stock Titan
After $1.8M stock sale, Twist Bioscience (NASDAQ: TWST) insider files to sell more - Stock Titan
Twist Bioscience CEO Emily Leproust sells $56.3m in company stock By Investing.com - Investing.com South Africa
Twist Bioscience (TWST) CEO trades 356K shares at up to $163.60 - Stock Titan
Weekly Recap: FY2026 revenue guide raised and Anthropic model review - TradingView
Twist Bioscience CorporationCommon Stock (NQ: TWST - The Chronicle-Journal
Twist Bioscience Corp (0ME) Q1 2026 Earnings ReportResults, Call & Slides - TipRanks
Twist Bioscience Corp (0ME) Q1 2025 Earnings ReportResults, Call & Slides - TipRanks
Why Twist Bioscience Stock Skyrocketed This Week - Yahoo Finance
TWST Jumps As Twist Bioscience Lands Eli Lilly AI Drug Discovery Deal - StocksToTrade
Twist Bioscience (NASDAQ: TWST) holder eyes $44.7M stock sale - Stock Titan
New multimillion-dollar stock sale planned at Twist Bioscience (NASDAQ: TWST) - Stock Titan
Twist Bioscience Stock Jumps 11% on Lilly TuneLab Deal, but the Revenue Terms Are Missing - TechStock²
Finanzdaten der Twist Bioscience Corp-Aktie (TWST)
Umsatz
Nettogewinn
Free Cashflow
ENV
Twist Bioscience Corp-Aktie (TWST) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Laponis Adam | Chief Financial Officer |
Oct 02 '26 |
Sale |
188.88 |
8,057 |
1,521,838 |
100,576 |
| Green Paula | SVP of Human Resources |
Oct 02 '26 |
Sale |
188.88 |
10,088 |
1,905,462 |
106,632 |
| Finn Patrick John | President and COO |
Oct 02 '26 |
Sale |
188.88 |
25,714 |
4,856,963 |
185,088 |
| Leproust Emily M. | Chief Executive Officer |
Oct 02 '26 |
Sale |
188.88 |
45,736 |
8,638,799 |
567,308 |
| Leproust Emily M. | Chief Executive Officer |
Oct 01 '26 |
Sale |
200.00 |
655 |
131,000 |
613,044 |
| Cho Dennis | See Remarks |
Oct 02 '26 |
Sale |
188.88 |
9,514 |
1,797,042 |
63,789 |
| WERNER ROBERT F. | Chief Accounting Officer |
Oct 02 '26 |
Sale |
188.88 |
1,482 |
279,926 |
42,917 |
0.99%
0.56%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):